Dyne Therapeutics Inc (DYN)
23.99
-0.31
(-1.28%)
USD |
NASDAQ |
Dec 20, 16:00
25.18
+1.19
(+4.96%)
After-Hours: 20:00
Dyne Therapeutics Total Assets (Quarterly): 768.84M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 22.24B |
| Regenxbio Inc | 519.11M |
| Avidity Biosciences Inc | 1.641B |
| Catalyst Pharmaceuticals Inc | 772.01M |
| Sarepta Therapeutics Inc | 3.600B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 63.30M |
| Shareholders Equity (Quarterly) | 705.54M |